CMILF yields 2628.12% · MRK yields 2.76%● Live data
📍 CMILF pulled ahead of the other in Year 1
Combined, CMILF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CMILF + MRK for your $10,000?
Capella Minerals Limited, together with its subsidiaries, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It primarily explores for gold, copper, and lithium deposits, as well as for silver and zinc deposits. The company holds 100% interests in the Southern Gold Line project in Sweden; Hessjøgruva Project located in the northern Røros Mining District, Norway; Vaddas-Birtavarre Copper-Cobalt project in northern Norway; and Kjøli and Løkken Project in the Trøndelag County. It also holds interests in the Domain, Manitoba, and Savant Lake projects in Ontario, Canada; Aakenus-Katajavaara project in northern Finland; Perho project located in Southern Finland; and Sierra Blanca Gold-Silver Project in Santa Cruz, Argentina. The company was formerly known as New Dimension Resources Ltd. and changed its name to Capella Minerals Limited in November 2020. Capella Minerals Limited was incorporated in 2005 and is based in Mission, Canada.
Full CMILF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.